Skip to main content
Top
Published in: Cancer & Metabolism 1/2015

Open Access 01-12-2015 | Research

Evidence that 2-hydroxyglutarate is not readily metabolized in colorectal carcinoma cells

Authors: Susan J. Gelman, Nathaniel G. Mahieu, Kevin Cho, Elizabeth M. Llufrio, Timothy A. Wencewicz, Gary J. Patti

Published in: Cancer & Metabolism | Issue 1/2015

Login to get access

Abstract

Background

Two-hydroxyglutarate (2HG) is present at low concentrations in healthy mammalian cells as both an L and D enantiomer. Both the L and D enantiomers have been implicated in regulating cellular physiology by mechanisms that are only partially characterized. In multiple human cancers, the D enantiomer accumulates due to gain-of-function mutations in the enzyme isocitrate dehydrogenase (IDH) and has been hypothesized to drive malignancy through mechanisms that remain incompletely understood. While much attention has been dedicated to identifying the route of 2HG synthesis, the metabolic fate of 2HG has not been studied in detail. Yet the metabolism of 2HG may have important mechanistic consequences influencing cell function and cancer pathogenesis, such as modulating redox potential or producing unknown products with unique modes of action.

Results

By applying our isotope-based metabolomic platform, we unbiasedly and comprehensively screened for products of L- and D-2HG in HCT116 colorectal carcinoma cells harboring a mutation in IDH1. After incubating HCT116 cells in uniformly 13C-labeled 2HG for 24 h, we used liquid chromatography/mass spectrometry to track the labeled carbons in small molecules. Strikingly, we did not identify any products of 2HG metabolism from the thousands of metabolomic features that we screened. Consistent with these results, we did not detect any significant changes in the labeling patterns of tricarboxylic acid cycle metabolites from wild type or IDH1 mutant cells cultured in 13C-labeled glucose upon the addition of L, D, or racemic mixtures of 2HG. A more sensitive, targeted analysis revealed trace levels of isotopic enrichment (<1 %) in some central carbon metabolites from 13C-labeled 2HG. However, we found that cells do not deplete 2HG from the media at levels above our detection limit over a 48 h time period.

Conclusions

Taken together, we conclude that 2HG carbon is not readily transformed in the HCT116 cell line. These data indicate that the phenotypic alterations induced by 2HG are not a result of its metabolic products.
Literature
1.
go back to reference Gregersen N, Ingerslev J, Rasmussen K. Low molecular weight organic acids in the urine of the newborn. Acta Paediatr Scand. 1977;66(1):85–9.CrossRefPubMed Gregersen N, Ingerslev J, Rasmussen K. Low molecular weight organic acids in the urine of the newborn. Acta Paediatr Scand. 1977;66(1):85–9.CrossRefPubMed
2.
go back to reference Wanders RJ, Mooyer P. D-2-hydroxyglutaric acidaemia: identification of a new enzyme, D-2-hydroxyglutarate dehydrogenase, localized in mitochondria. J Inherit Metab Dis. 1995;18(2):194–6.CrossRefPubMed Wanders RJ, Mooyer P. D-2-hydroxyglutaric acidaemia: identification of a new enzyme, D-2-hydroxyglutarate dehydrogenase, localized in mitochondria. J Inherit Metab Dis. 1995;18(2):194–6.CrossRefPubMed
9.
go back to reference Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462(7274):739-44. doi:10.1038/nature08617.PubMedCentralCrossRefPubMed Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462(7274):739-44. doi:10.1038/nature08617.PubMedCentralCrossRefPubMed
10.
16.
go back to reference Kolker S, Pawlak V, Ahlemeyer B, Okun JG, Horster F, Mayatepek E et al. NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d-2-hydroxyglutaric aciduria. Eur J Neurosci. 2002;16(1):21–8.CrossRefPubMed Kolker S, Pawlak V, Ahlemeyer B, Okun JG, Horster F, Mayatepek E et al. NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d-2-hydroxyglutaric aciduria. Eur J Neurosci. 2002;16(1):21–8.CrossRefPubMed
21.
go back to reference Ivanisevic J, Zhu ZJ, Plate L, Tautenhahn R, Chen S, O'Brien PJ et al. Toward 'omic scale metabolite profiling: a dual separation-mass spectrometry approach for coverage of lipid and central carbon metabolism. Anal Chem. 2013;85(14):6876-84. doi:10.1021/ac401140h.PubMedCentralCrossRefPubMed Ivanisevic J, Zhu ZJ, Plate L, Tautenhahn R, Chen S, O'Brien PJ et al. Toward 'omic scale metabolite profiling: a dual separation-mass spectrometry approach for coverage of lipid and central carbon metabolism. Anal Chem. 2013;85(14):6876-84. doi:10.​1021/​ac401140h.PubMedCentralCrossRefPubMed
27.
go back to reference Cho K, Mahieu NG, Ivanisevic J, Uritboonthai W, Chen YJ, Siuzdak G et al. isoMETLIN: A Database for Isotope-Based Metabolomics. Anal Chem. 2014. doi:10.1021/ac5029177. Cho K, Mahieu NG, Ivanisevic J, Uritboonthai W, Chen YJ, Siuzdak G et al. isoMETLIN: A Database for Isotope-Based Metabolomics. Anal Chem. 2014. doi:10.​1021/​ac5029177.
28.
Metadata
Title
Evidence that 2-hydroxyglutarate is not readily metabolized in colorectal carcinoma cells
Authors
Susan J. Gelman
Nathaniel G. Mahieu
Kevin Cho
Elizabeth M. Llufrio
Timothy A. Wencewicz
Gary J. Patti
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Cancer & Metabolism / Issue 1/2015
Electronic ISSN: 2049-3002
DOI
https://doi.org/10.1186/s40170-015-0139-z

Other articles of this Issue 1/2015

Cancer & Metabolism 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine